Xultophy Injection 100IU/3.6mg

About Xultophy Injection 100IU/3.6mg

Xultophy Injection Uses

• Type 2 diabetes that is not controlled well enough with oral medicines alone.
• Cases where a patient already uses basal insulin or a GLP-1 medicine and needs better control.
• Long term blood sugar management alongside diet and exercise.
• Situations where a doctor prefers one combined injection instead of two separate ones.

Xultophy Injection Benefits

• One daily injection combines two proven diabetes medicines in a single pen.
• Blood sugar control tends to improve with fewer injections than separate insulin and GLP-1 therapy.
• Weight gain is often lower compared to insulin used alone, since liraglutide can support modest weight loss.
• The dose is adjustable in single steps, allowing gradual and careful titration.

What Experts Say

Xultophy combines a long acting basal insulin with a GLP-1 receptor agonist, and Pakistani physicians increasingly view this pairing as useful for patients who need stronger glucose control without the complexity of multiple daily injections. The two components act through different pathways, which allows a lower insulin dose overall.

In Pakistan, type 2 diabetes is diagnosed at a young age compared to many other regions, and long term insulin therapy is often needed for decades. A combination like this can reduce the pill and injection burden while still targeting both fasting and post meal glucose levels effectively.

Clinical guidance from Pakistani endocrinologists generally recommends this combination once metformin and other oral drugs no longer provide adequate control. Regular monitoring for hypoglycemia and gradual dose titration remain central to safe and effective long term use.

Drug Class

• Combination Antidiabetic: Basal Insulin Analog (Insulin Degludec) plus GLP-1 Receptor Agonist (Liraglutide)

Xultophy Injection 100IU/3.6mg formula

• Insulin Degludec 100 Units/mL + Liraglutide 3.6 mg/mL

Available forms

• Injection

How to use Xultophy Injection 100IU/3.6mg?

• The pen delivers one injection under the skin, once daily at the same time each day.
• The abdomen, thigh or upper arm are suitable injection sites, rotated with each dose.
• A new needle is required for every injection, and the pen is primed before first use.
• The dose is set only as prescribed by the treating doctor, based on blood sugar readings.
• Mixing this pen with any other insulin or injectable medicine is not recommended.

Drug Interactions

• Beta Blockers: These medicines can hide the usual warning signs of low blood sugar, such as a fast heartbeat.
• Other Antidiabetic Drugs: Sulfonylureas and other insulins raise the chance of hypoglycemia when combined with this pen.
• Corticosteroids: Steroid medicines can raise blood sugar and reduce the effectiveness of this treatment.
• Oral Diabetes Pills: A dose adjustment is often needed when this pen is combined with other glucose lowering tablets.

Risks and warnings

• Thyroid Tumor Risk: The liraglutide component may raise the risk of thyroid C-cell tumors seen in animal studies. Patients with a personal or family history of medullary thyroid cancer should not use this medicine.
• Hypoglycemia: Low blood sugar is possible, especially when combined with other diabetes medicines. Shakiness, sweating and confusion are early warning signs.
• Pancreatitis: Severe stomach pain with nausea and vomiting can signal inflammation of the pancreas. Immediate medical care is needed if this occurs.
• Not For Type 1 Diabetes: This pen is not suitable for type 1 diabetes or diabetic ketoacidosis.
• Kidney Function: Dose adjustments may be necessary for patients with reduced kidney function.

Xultophy Injection Side Effects

• Low blood sugar (hypoglycemia)
• Nausea and reduced appetite
• Diarrhea and mild stomach upset
• Injection site redness or itching
• Headache
• Vomiting
• Indigestion
• Gradual weight loss
• Rare gallbladder problems with long term use

Storage Conditions

• Store unopened pens in a refrigerator between 2C and 8C, away from the freezer compartment.
• Keep the pen in use at room temperature below 30C for a maximum of 21 days, then discard it.
• Protect the pen from direct sunlight and excess heat at all times.
• Replace the pen cap after every injection to shield the medicine from light.
• Never share this pen with another person, even with a new needle attached.